Medindia
Medindia LOGIN REGISTER
Advertisement

Osteotech Announces First Quarter 2010 Financial Results Release and Conference Call

Monday, May 3, 2010 General News
Advertisement


EATONTOWN, N.J., May 3 Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced today that the Company's first quarter ended March 31, 2010 financial results will be released before the market opens on Monday, May 10, 2010. The management team of Osteotech will host a conference call and webcast on Monday, May 10, 2010, at 9:00 a.m. (EDT) to discuss the Company's financial results, recent accomplishments and 2010 goals. The call can be accessed by dialing 1-866-783-2142 (domestic) or 1-857-350-1601 (international) and indicating access code 45753886. A replay of the call will be available two hours after completion of the live call through midnight, Monday, May 24, 2010 by dialing 1-888-286-8010 and indicating access code 86998695.
Advertisement

A live, listen-only webcast of the conference call will also be available at the Company's investor site at http://www.osteotech.com on the Financial Highlights page. A replay of the conference call and the question/answer session will be available at the Company's website for approximately 14 days following the call.
Advertisement

About Osteotech

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing biologic solutions for regenerative medicine to support surgeons and their patients through the development of innovative therapy-driven products that alleviate pain, promote regenerative and biologic healing and restore function. For further information regarding Osteotech or this press release, please go to Osteotech's website at http://www.osteotech.com.

SOURCE Osteotech, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close